29 December 2023 in Arquivos de Neuro-Psiquiatria
REM sleep behavior disorder (RBD) is characterized by a loss of atonia of skeletal muscles during REM sleep, associated with acting out behaviors during dreams. Knowledge of this pathology is important to predict neurodegenerative diseases since there is a strong association of RBD with diseases caused by the deposition of alpha-synuclein in neurons (synucleinopathies), such as Parkinson's disease (PD), multiple system atrophy (MSA), and dementia with Lewy bodies (DLB). Proper diagnosis of this condition will enable the use of future neuroprotective strategies before motor and cognitive symptoms. Diagnostic assessment should begin with a detailed clinical history with the patient and bed partner or roommate and the examination of any recorded home videos. Polysomnography (PSG) is necessary to verify the loss of sleep atonia and, when documented, the behaviors during sleep. Technical recommendations for PSG acquisition and analysis are defined in the AASM Manual for the scoring of sleep and associated events, and the PSG report should describe the percentage of REM sleep epochs that meet the criteria for RWA (REM without atonia) to better distinguish patients with and without RBD. Additionally, PSG helps rule out conditions that may mimic RBD, such as obstructive sleep apnea, non-REM sleep parasomnias, nocturnal epileptic seizures, periodic limb movements, and psychiatric disorders. Treatment of RBD involves guidance on protecting the environment and avoiding injuries to the patient and bed partner/roommate. Use of medications are also reviewed in the article. The development of neuroprotective medications will be crucial for future RBD therapy.
1 June 2026 in Sleep Science
Adapting the American Academy of Sleep Medicine (AASM) Guidelines for restless legs syndrome (RLS) to Latin America is a complex challenge, given the region's 33 countries and vast socioeconomic diversity. Such an endeavor requires comprehensive data and consensus from a broader representation of these populations. There is a need to assess the effect of social vulnerability on the prevalence of symptoms of periodic leg movements that may be erroneously called RLS and mimic the primary nosological diagnosis for itself. We aim to discuss the Asociación Lationoamericana de Sueño's (Latin American Sleep Association, ALADS, in Spanish) position statement to contextualize the 2025 AASM clinical practice guidelines for the treatment of RLS and periodic limb movement disorder. Their intention of advocating for future systematic studies employing standardized criteria in Latin America. While the Scientific Committee for Sleep Disorders of the Brazilian Academy of Neurology partially endorses those opinions, offering some counterpoints concerning, especially, the following issues: 1) challenges to the reportedly wide variability in Latin American RLS prevalence, with apparently very high prevalences exceeding the expected values in some locations; 2) the importance of complementing clinical history with structured RLS diagnostic questionnaires; and 3) amendments to the proposed summary of treatment recommendations, particularly regarding Iron supplementation. Finally, the presence of comorbidities and RLS in epidemiological studies must be considered and data from Latin America can contribute to the discussion on global criteria applied worldwide for RLS that need to be revised according to regional, social, and cultural issues.